Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04784598
Other study ID # UFRNheelpain
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 16, 2022
Est. completion date January 1, 2023

Study information

Verified date January 2023
Source Universidade Federal do Rio Grande do Norte
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Introduction: Persistent hindfoot pains are very common and prevalent complaints in the Brazilian population. One of the treatments recommended for these conditions in the literature is the use of insoles. However, to use this resource it is necessary that the individual wear closed shoes and this is an obstacle to treatment in cities with hot climate. Thinking about an alternative treatment, the customized slippers with the corrective elements of the insoles can be an alternative to increase adherence to this type of treatment. Objective: To compare different types of hindfoot elements in insoles adapted in slippers in individuals with persistent hindfoot pain.


Description:

Methodology: This is a protocol for a controlled, randomized, blinded clinical trial. Eighty participants with persistent hindfoot pain will be evaluated and randomized into two intervention groups: insoles adapted to flip-flops and flip-flops with sham insole. The evaluations will be carried out at baseline (T0), after six (T6) and twelve weeks (T12) of the use of flip-flops, in addition to the follow-up that will be carried out four weeks after the end of the intervention (T16). The primary outcome will be pain, using the Numerical Pain Scale and the secondary outcomes will be: foot function, using the Foot Function Index questionnaire, functional capacity in walking, using the Six-Minute Walk Test and pain catastrophizing using the Scale. of Pain Catastrophizing. Statistical analysis: Data will be analyzed by T-student, Mann-Whitney and repeated measures ANOVA tests and will be analyzed by intention to treat. Ethics and disclosure: This protocol was approved by the Ethics Committee of UFRN/FACISA (number 4,018,821). The results of the study will be disseminated to participants and submitted to a peer-reviewed journal and scientific meetings.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date January 1, 2023
Est. primary completion date October 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Individuals of both sexes, aged 18 to 65 years; - Persistent heel pain for at least three months based on self-reported criteria: heel pain accompanying the first steps in the morning, after a period of inactivity, and/or during prolonged weight-bearing; - Pain intensity between 3 and 8 points, according to the Numerical Rating Scale (NRS) [22]; - Individuals who can wear flip-flop sandals for at least four hours per day for 12 weeks. Exclusion Criteria: - Clinical diagnosis of neuropathic pain or neurodegenerative disorders, persistent heel pain due to rheumatic conditions, and previous ankle and foot surgeries; - Physical therapy treatment in the last three months; - Corticosteroid injection into feet in the last six months; - inability to answer study-related questionnaires; - Individuals scheduled to travel in the next six months.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Insoles adapted in flip-flop sandals
participants of both groups individually received a pair of customized flip-flop sandals, with or without foot pieces, covered with smooth synthetic leather

Locations

Country Name City State
Brazil Marcelo Cardoso de Souza Natal RN

Sponsors (1)

Lead Sponsor Collaborator
Universidade Federal do Rio Grande do Norte

Country where clinical trial is conducted

Brazil, 

References & Publications (1)

Costa ARA, de Almeida Silva HJ, Mendes AAMT, Scattone Silva R, de Almeida Lins CA, de Souza MC. Effects of insoles adapted in flip-flop sandals in people with plantar fasciopathy: a randomized, double-blind clinical, controlled study. Clin Rehabil. 2020 M — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Numerical pain intensity scale - NPS Pain intensity will be evaluated with the 10-point Numerical Pain Rating Scale, where 0 is "pain-free" and 10 is "maximum pain. baseline, 6 weeks after, 12 weeks after, 16 weeks folow up
Secondary Change in Foot function - FFI Brazilian version of the Foot Function Index questionnaire.15 This questionnaire aims to evaluate the functionality of the foot and is divided into three subscales, which are pain, difficulty and functional limitation. The outcome of all domains was summed and divided by three to achieve the final result of the questionnairewhich can vary from 0% to 100%, and are proportional to functional impairment of the limb.The higher the percentage, the greater the functional alteration presented by the patient baseline, 6 weeks after, 12 weeks after, 16 weeks folow up
Secondary Change in Functional capacity - 6MWT For this test, the participant walked at full speed for 6minutes along a 30-m lane, and the total distance was recorded. baseline and 12 weeks after
Secondary Change in Pain Catastrophizing Scale (PCS) Self-administered questionnaire composed of 13 items in which the individual reports the degree of thought or feeling on a 5-point Likert scale. The instrument has three subscales (hopelessness, magnification, and rumination), and the total score (0 to 52 points) is obtained by summing items. The higher the value, the greater the level of catastrophizing baseline and 12 weeks after
Secondary Expectation for treatment The scale assesses the expectations of individuals at the beginning of the study regarding treatment received. The question "Do you think that with flip-flop sandals you will" (1) get very worse, (2) get a little worse, (3) neither improve nor get worse, (4) improve a little, or (5) improve a lot. This scale will be applied only in the first (T0) assessment baseline
Secondary Satisfaction with treatment The scale will assess perceptions of the individual on the effects of treatment through the following question: "After using flip-flop sandals with insoles are you feeling" (1) much worse, (2) a little worse, (3) neither better nor worse, (4) a little better, or (5) much better 16 weeks after
See also
  Status Clinical Trial Phase
Completed NCT04060576 - Post-needling Soreness After Internal Gastrocnemius Muscle Treatment N/A
Recruiting NCT06074640 - Effects of PIR With and Without Dry Needling on Heel Pain N/A
Recruiting NCT05885243 - Evaluation of the Efficiency of ESWT and Custom İnsoles Produced With Podometric Measurement in the Treatment of Painful Heel Spurs (ESWT: Extracorporeal Shock Wave Therapy) N/A
Not yet recruiting NCT06456944 - Effect of Selected Rehabilitation Program in Patients With Plantar Fasciitis N/A
Completed NCT04380285 - Treating Heel Pain in Adults: A Randomized Clinical Trial of Hard Versus Soft Orthotics N/A
Not yet recruiting NCT05075434 - Effects of the Diacutaneous Fibrolysis Approach in Patients With Plantar Fasciitis. N/A
Completed NCT04378270 - Validation of a Novel Foot Offloading Device N/A
Completed NCT01355640 - Two Methods of Analgesia for Chinese Term Infants Receiving Heel Lance N/A
Completed NCT03482518 - Effectiveness of Postural Insoles Adapted in Slippers for People With Persistent Heel Pain N/A
Not yet recruiting NCT05810818 - Effectiveness Of DN and STM Combined With Self-Stretching for Management of Calf and Heel Pain N/A